A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa

NCT02448680 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A With Inhibitors
Hemophilia B With Inhibitors

Interventions

BIOLOGICAL: Coagulation FVIIa (Recombinant)

Sponsor

Laboratoire français de Fractionnement et de Biotechnologies

Collaborators

[object Object]